chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-337525, MOD-2021-337582 (Patient Link).
redness; swelling; This case was reported by a pharmacist and described the occurrence of injection site erythema in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were unknown.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix.  Additional details were provided as follows: The patient's pre-screening sheet reported nothing. The age at vaccination was not reported. The patient received 1st dose of Shingrix and experienced injection site swelling and redness. For tolerance after 2nd dose of Shingrix, refer case US2019106103, reported for same patient.
48 hours post inject a large red splotch appeared below injection site going down my arm.  This did not happen with my first two injections
Hurt and swollen arm; had some pain with prior doses but nothing compared to this; Injection site is hot at touch; Patient's left arm hurts; scoliosis pain 24x7; sciatic pain; back pain 24/7; This spontaneous case was reported by a non-health professional and describes the occurrence of PERIPHERAL SWELLING (Hurt and swollen arm), PAIN (had some pain with prior doses but nothing compared to this), VACCINATION SITE WARMTH (Injection site is hot at touch), PAIN IN EXTREMITY (Patient's left arm hurts) and SCOLIOSIS (scoliosis pain 24x7) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sciatica (Pain medication is used) and Walking difficulty. Concurrent medical conditions included Scoliosis (Pain medication is used).   On 24-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Hurt and swollen arm), PAIN (had some pain with prior doses but nothing compared to this), VACCINATION SITE WARMTH (Injection site is hot at touch), PAIN IN EXTREMITY (Patient's left arm hurts), SCOLIOSIS (scoliosis pain 24x7), SCIATICA (sciatic pain) and BACK PAIN (back pain 24/7). At the time of the report, PERIPHERAL SWELLING (Hurt and swollen arm), PAIN (had some pain with prior doses but nothing compared to this), VACCINATION SITE WARMTH (Injection site is hot at touch), PAIN IN EXTREMITY (Patient's left arm hurts), SCOLIOSIS (scoliosis pain 24x7), SCIATICA (sciatic pain) and BACK PAIN (back pain 24/7) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   NO concomitant medication reported.  Patient is on Pain medication for scoliosis & sciatic pain.
Pfizer-BioNTech COVID-19 Vaccine EUA - Patient with history of anaphylaxis requiring intubation to benzonatate.  Patient answered "no" to questionnaire about allergic reactions prior to vaccination.  11 minutes after vaccination, patient reported tingling of lips and swelling of face. Developed hoarseness. SWAT was called and patient given benadryl and taken to ED (1055). Patient received steroids and H1/H2 blockers in addition to epinephrine.  Patient brought to ICU for monitoring.  Patient continued on therapy and was discharged 1/2 at 1113. Patient returned to ED on 1/3 at 1558  with macular papular rash on leg, chest and back with itching on eyelids and face.  No respiratory involvement. Patient given benadryl and predinisone and discharged from ED at 2016.
painful; shingles-like feeling; red; the ones by my ankles are getting big; very itchy; They were red; they're starting to turn purple; they started popping up all over legs, arms, bottoms of my feet, palms of my hands, face, lower back/ about 25 of them on each hand and foot/ more on my hands and feet than anywhere else; raised bumps on her fingers on the left hand/ they started popping up all over; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PAPULAR (raised bumps on her fingers on the left hand/ they started popping up all over), PAIN (painful), HERPES ZOSTER (shingles-like feeling), RASH ERYTHEMATOUS (red) and OEDEMA PERIPHERAL (the ones by my ankles are getting big) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chickenpox (Patient had chickenpox at the age of 6.).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced RASH PAPULAR (raised bumps on her fingers on the left hand/ they started popping up all over). On 21-Mar-2021, the patient experienced RASH (they started popping up all over legs, arms, bottoms of my feet, palms of my hands, face, lower back/ about 25 of them on each hand and foot/ more on my hands and feet than anywhere else). On 22-Mar-2021, the patient experienced SKIN DISCOLOURATION (They were red; they're starting to turn purple). On an unknown date, the patient experienced PAIN (painful), HERPES ZOSTER (shingles-like feeling), RASH ERYTHEMATOUS (red), OEDEMA PERIPHERAL (the ones by my ankles are getting big) and RASH PRURITIC (very itchy). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form and NAPROXEN at a dose of 1 dosage form. At the time of the report, RASH PAPULAR (raised bumps on her fingers on the left hand/ they started popping up all over), PAIN (painful), HERPES ZOSTER (shingles-like feeling), RASH ERYTHEMATOUS (red), OEDEMA PERIPHERAL (the ones by my ankles are getting big), SKIN DISCOLOURATION (They were red; they're starting to turn purple), RASH PRURITIC (very itchy) and RASH (they started popping up all over legs, arms, bottoms of my feet, palms of my hands, face, lower back/ about 25 of them on each hand and foot/ more on my hands and feet than anywhere else) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported.   The ones by her ankles are getting big, but she's not sure if it's from her shoes rubbing on them.
Headache on the L side of his head, and the L side of his neck was "tight" and sore, with a tingling sensation going down the L arm to his thumb. Those Sx have resolved with ibuprofen. On 2/3/19 he developed a non-pruritic rash on the L side of his neck, it has since spread up onto his L cheek and on the L side of his chest. Rash is not painful, but feels sensitive when touched. Not oozing.
Fever (100.6) and chills next day at 2 AM. Tylenol 1000mg cleared up symptoms. Fever at 4 PM next day as well. Tylenol cleared symptoms.  I had mild case of Covid in July 2020. This seems to be a common response for Covid survivors after first dose. Not looking forward to next dose. CDC should consider recommending Covid survivors receive only one dose and there are plenty of studies supporting this treatment recommendation. My body?s immune response was strong and I don?t think i need second dose.
C/O nausea, vision started to blur, facial sweating, sweating on scalp and arms, dizziness :,slow speech: no sign of stroke: Pt denies CP/Press,.  Vision improved; sweating ceased .Pt provided with Gatorade to increase  glucose level. Symptoms resolved with time,instructed to F/U with PCP.
< 30 minutes after injection patient developed erythema of hands, face, back and within moments of examining her lungs, she became dizzy, Blood pressure was 80 palp. She was administered Benadryl 50mg IM and Epi 0.3cc subq. and while transferring her to a stretcher, she passed out momentarily. Rushed her to ER- they took over.
pt recvd vax; 6 days after vax pt devel t 104, building fontanels, stiff neck, lg peeling blisters on buttocks; periods of irritability & sleepiness; dx - strep pneumococial, meningoencepalitis, ventromegaly multi cerebral infacts;
Initial pregnancy report received from a healthcare professional on 09 April 2013. A 31-year-old female patient, who had no medical history, had received intramuscular first dose of ADACEL (lot number: C4366AA, site of vaccination was not reported) on 09 April 2013. The patient was pregnant during vaccination. The patient's date of last menstrual period was reported as 08 September 2012 and the estimated date of delivery is 25 June 2013. At the time of the report, the patient had not experienced any adverse event. List of documents held by sender none. Follow-up information received from a healthcare professional on 19 August 2013: The patient had chronic gastritis at the time of vaccination. The patient also had nausea and GERD (Gastro Esophageal Reflux disease). The patient was taking ZOFRAN 8 mg for nausea and PROTINIX 40 mg for Nausea/GERD. The patient had not received any treatment for infertility. The patient had no previous pregnancies. The patient had no family history of congenital anomaly. The patient received ADACEL in left deltoid. The patient had no any risk factors during pregnancy. The patient's pre-pregnancy weight was 237 lbs. and height was 5.4 feet while weight at delivery was 245 lbs. The prenatal test done on an unspecified date revealed normal results. At 39 weeks of gestation, the patient delivered a female child weighing 4/02 kg. The height of the baby was 51 cm and APGAR score at 1 minute was 9 and at 5 minute was 10. The baby had no any congenital anomaly.
5 days p/vax pt devel a red raised rash localized to the deltoid area;stated that on arms was fine until 5 days post vax;stated that it became very itchy & scratched it;went to MD who stated had a cellulitis;
This case was reported by a lawyer and described the occurrence of hearing los sin a male subject of unspecified age who was vaccinated with Lyme disease vaccine recombinant OSPA Lymerix, for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Lymerix (unknown). An unspecified time after vaccination with Lymerix, the subject experienced hearing loss, arthralgia, fatigue, headache, visual problem, tingling sensation, rash, sinus problems, swollen joint, gastrointestinal disorder, burning sensation, nerve injury, myalgia, fever, chills, nausea, bone pain,m rheumatological symptoms, neurological impairment, cognitive impairment, autoimmune disease, decreased ability to perform daily activities and decreased ability to participate in recreational activities. This case was assessed as medically serious by manufacturer (OMIC). At the time of reporting the outcome of the events was unspecified. This information was received via a statement of injuries.
Incessant crying, difficulty breathing (may be related to the crying), redness and swelling around injection site.
Patient felt faint, dizzy, and warm within one to two minutes after receiving the vaccine. She reports that she typically faints in response to vaccinations in the past. Symptoms lasted approximately 25 minutes and resolved without medical treatment.
1st dose 10Dec2021, not had 2nd dose; Muscle soreness; This case was reported by a consumer via call center representative and described the occurrence of muscle soreness in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 10th December 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On 10th December 2021, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced muscle soreness. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the muscle soreness was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the muscle soreness to be related to Shingrix.     Additional Information: GSK Receipt Date: 17-AUG-2022 Reporter's comment: The patient self-reported this case. The patient received 1st dose of Shingrix vaccine and experienced muscle soreness that had since resolved. The patient stated that he did not receive his second dose of Shingrix as of now. The patient also stated that he will schedule an appointment to receive his second dose of Shingrix as soon as possible.  The patient gave medical disclaimer. Referred to HCP (Health Care Professional). Spoke per PI (package insert) and content. The reporter consented to follow-up. Additional Supportive Information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to Incomplete course of vaccination.
Patient, c/o blurred vision, dizziness & sweating after MENACTRA admin.
sore arm - left arm; Muscle pain; Exhaustion; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm - left arm), PAIN (Muscle pain), FATIGUE (Exhaustion) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN (Muscle pain) and FATIGUE (Exhaustion). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm - left arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (sore arm - left arm), PAIN (Muscle pain), FATIGUE (Exhaustion) and HEADACHE (Headache) outcome was unknown.            No relevant concomitant medication was reported.  Treatment information was not provided.   Reporter did not allow further contact
Patient complaint of dull chest pain after leaving clinic room and walking to main lobby. Unable to pinpoint exact location of chest pain and unable to report exact duration of chest pain. When I arrived to the patient, she stated her chest pain had gone away. Vitals taken at 2:16 pm: BP-132/71, HR 71, 94% O2. Patient is on  2 Liters continuous oxygen via nasal cannula. Patient states she is taking "15 heart medications" and follows up routinely with cardiologist.  Patient not experiencing difficulty breathing, and having no difficulty speaking with me. Vitals taken again at 2:22 pm: BP-140/74, HR 70, 93% O2. Patient was monitored 10 minutes after last set of vitals where she continued to deny chest pain or difficulty breathing. Care was then turned over to assistant living staff to ensure patient got home safely.
Itchy knot; Red knot; Warm to the touch at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy knot), ERYTHEMA (Red knot) and INJECTION SITE WARMTH (Warm to the touch at the site of injection) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PRURITUS (Itchy knot), ERYTHEMA (Red knot) and INJECTION SITE WARMTH (Warm to the touch at the site of injection). At the time of the report, PRURITUS (Itchy knot), ERYTHEMA (Red knot) and INJECTION SITE WARMTH (Warm to the touch at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information and concomitant medications were reported.
Cold chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Cold chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Cold chills). At the time of the report, CHILLS (Cold chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was unknown by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NNI
After the vaccine I immediately got a mild minor headache which passed pretty quickly.  At around 9pm I noticed a bump at the base of my neck on the top of my right collar bone.  I reached out to Employee Health Nurse and my PCPs nurse who agreeed it could possibly be a swollen lymph node.  Today I am currently monitoring this bump and if it doesnt desolve I will reach out to my PCP in the morning.
Pain in knees.  some swelling, and pain in lower legs.  States MD ruled out blood clots
8/19/04 mom called stated child will not move RA since received vaccines on 8/16/04; advised to bring the assessment or F/U with PMD 8/20/04. Dr called client at office unable to move arm has stiffness and some type of inflammatory tendonitis; MD says no local reaction redness or swelling seen.
Information has been received from a nurse concerning a 33 year old female patient with fibromyalgia, migraine headache, anaemia, hypothyroidism and drug allergies to AUGMENTIN, BIAXIN and BACTRIM who on 09-DEC-2010 was vaccinated IM with PNEUMOVAX 23 (lot # 667416/0956Z). Concomitant therapy included ACIPHEX, montelukast sodium (MSD), CELEBREX, LYRICA, SYNTHROID, BENTYL and gabapentin. On 13-DEC-2010 the patient reported having fever, chills, body ache, nausea, a stuffy nose and generally not feeling well. The patient also had a topical reaction. She had two areas near the injection site. One was 1 cm below the site and was 1 cm across. The other was 8 cm below the injection site and was 3 cm across. Both areas were papular with an irregular border. The sites were painful and the patient had difficulty raising her arm. They treated the patient with TORADOL, PHENERGAN and ROCEPHIN. They have not seen the patient again so did not know her current situation. Follow up information has been received from the registered nurse reporting that the patient was vaccinated with the first dose of PNEUMOVAX 23 (lot # 667416/0956Z) by subcutaneous injection at the left arm. She developed left arm redness and significant left arm pain the day after vaccination (on 10-DEC-2010). The patient also had a 1 cm papular reddened area 1 cm below injection site and a second 3 cm area 8 cm below injection site. At the time of reporting, the outcome was unknown. Additional information has been requested.
This spontaneous report was received from a medical assistant refers to a multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On multiple unspecified dates, the multiple unspecified patient's were vaccinated with improperly stored VARIVAX (lot # M000997 and expiration date 07-JAN-2018) (lot # M006731 and expiration date 09-FEB-2018) (lot # M027345 and expiration date 06-JAN-2018) (dose and route of administration not reported for all the lots). The administered doses experienced a temperature excursion of 19 Fahrenheit for 18 hours. There were no previous temperature excursions. The call was because of a data logger. No adverse effects were reported. No product quality complaint (PQC) was filed. Additional information has been requested.
On Saturday, March 6th, I developed a raised, oval-ish, red, warm, rash-like mark on my left arm right around the point of injection.  It was about 1-1.5 inches in diameter.  It did not ich, but was slightly sore.  The mark faded to a purplish color and was no longer sore (unless pressure was applied) by Monday, 3/6.  It however was still warm and slightly raised. On this day, 3/6, I had a visit with my Doctor who recommended I connect with the clinic that provided the vaccination as she believes this is a reaction to the vaccine. Today, 3/12, the spot is a very fait purplish mark on my arm, no other symptoms.  Besides my arm I have not experienced any other reactions or symptoms.
Our intern came to help out with the vaccines and processing them, at the store I was floating to. I took out the vaccine from the refrigerator to thaw. I indicated to her as such. But  there were 2 vials( 1 Pfizer+ 1 Moderna) left over from yesterday(12/13) sitting on the other side of the back counter, with a sticker on the bottom indicating the time and date. She thought I already prepared the vaccines and ready to go. So she started giving  vaccines from those vials.  After giving the 2 Pfizer and 3 Moderna vaccines, she realized that it was a bottle from yesterday. She alerted me as such .  None of the patients called back reporting any adverse effects. we reported to out patient care services manager. He is looking in to all the details
Patient received a flu shot, Fluzone 0.5 ml I.M. in the rt. deltoid at approximately 9:20 a.m. Friday, December 5, 2003. She denied any allergies, but had "never had a flu shot before." "After going to bed that night, she awakened approximately 1 a.m. Saturday morning because of pain in her arm." She noticed a small bruise at the injection site, but states there was no redness or swelling. She applied a cool compress and took an O.T.C. pain medication. She called the Health Dept. on Tuesday 12/9/2003 and was advised to call her physician. When I spoke with her today Wednesday 12/10/03 she stated she is still having difficulty and her physician stated there was little he could do for her. She would have to wait for it to resolve. She stated she was told to continue with her O.T.C. Meds and to apply warm moist compresses. She is following that advice.
Swelling of throat, getting harder to swallow. Vitals wnl. Given Benadryl 25 mg PO.